Periodical information
三才期刊采编系统
Acquisition System
（1993年创刊 半月刊）
Sponsors
Chinese Anti-cancer Association
Shaanxi Anti-cancer Association of China
Shaanxi Cancer Institute 
Editing & Publishing
Editorial Board of Journal of Modern Oncology
309 Yanta West Road Xi＇an Shaanxi Province 710061, P.R.China
Tel：0086-029-85578876
0086-029-85277356
0086-029-85276012
Fax:0086-029-85277356
http://www.xdzlyx.com/
E-mail：sxzlyx@263.net
Chief of Magazine Agency
Geng Qingyi(耿庆义)
Editor-in-Chief & Managing Director
Li Shuye(李树业)
Honorary editor in chief
Fan Daiming(樊代明)
Hao Xishan(郝希山)
Subscriptions
Domestic
Local Post Offices,China Post subscription code 52-297
Overseas
China International Book Trading Corporation
P.O.Box 399,Beijing 100044,China. Code No：M1985
Licence for Advertising
Shaanxi Industrial Commer-cial:6100004000094
Printing
Printing Branch of Xi＇an Haoxuan printing Co.Ltd 
CSSN
ISSN 1672-4992
CN 61-1415/R
Price
RMB ￥10.00
US $6.00
Journal introduction
  
    "Modern Oncology" (ISSN1672-4992, CN61-1415/R, semimonthly publication) is a nation-level domestic and foreign public released oncology periodical, proved by "Ministry of Chinese Science and Technique" and "News Publication Administration", also is one of the series periodicals of Chinese Anti-cancer Association. The journal is sponsored by Chinese Anti-cancer Association, Shaanxi Anti-cancer Association of China, Shaanxi Cancer Institute, Shaanxi Medical Academy of China and is managed by Shaanxi Scientific Technical Association. This journal is included by "Source Journals for Chinese Scientific and Technical Papers and Citations", "Chinese Scientific and Technical Core Periodical","A Guide to the Core Journals of China" , "Chemical Abstracts of USA", "Japan Science and Technology Agency(Chinese Bibliographic Database), JST China”， "Chinese Journal Net", "Chinese Academic Journal (CD-ROM Version) Full Text Database", "China Core Journals (Selection) Database", "Chinese Biomedical Literature Database", also is the full text internet journal of "Wanfang Data-Digital Periodical ", the source journal of "China Abstracts of Academic Periodicals"and "Chinese Medical Abstract•Oncology".更多...
Current Issue: 2024,Vol.32,NO.24
[4569-4579] Chinese expert consensus on diagnosis and treatment of ovarian cancer in the elderly
[LIU Junxiu1，CHEN Yili1，GAO Guolan2，CUI Heng3，ZHANG Ping4]
2024 24 [Abstract]()
[4580-4587] Effects of magnesium-L-threonate on migration and invasion ability and NF-κB/ TNF-alpha signaling pathway of non-small cell lung cancer H460 cells
[XIONG Ying1,SHEN Jingjiao2,LIU Xianguo3,ZHOU Xin1,4]
2024 24 [Abstract]()
[4588-4599] Targeted degradation of p38γ by hyperthermia inhibits proliferation of nasopharyngeal carcinoma cells
[WU Jingjing1,2，LI Huizhen2，SHI Shuling2，LI Peihong1,2，YANG Yuchuan2，ZHA Boya2，HUANGFU Linkuan2，LIANG Tiansong2，ZHENG Yingjuan2，YANG Daoke2]
2024 24 [Abstract]()
[4600-4607] PSMB9 regulates the PI3K/Akt signaling pathway to promote malignant biological behavior in esophageal squamous cell carcinoma
[YAN Ke,ZHANG Zhouhua,LI Zhifang,WEI Xingfang,ZHANG Li]
2024 24 [Abstract]()
[4608-4615] Risk factors analysis and model construction of cervical lymph node metastasis in papillary thyroid carcinoma
[XING Zhijing1,LU Dan1,ZHANG Qiaomeng1,ZHU Ping1,SHI Changbei2,YUAN Quan2,AN Yuan2,LI Lin1,2]
2024 24 [Abstract]()
[4616-4623] Clinicopathological characteristics analysis of non-small cell lung cancer patients with concomitant EGFR mutation and ALK fusion
[ZHAO Xilian1,DING Caixia1，YU Xueyan1,WANG Xiaomin1,GUO Yu1,ZHANG Juan1,HAN Le2,CHEN Wenjuan3,HAN Xiuping4]
2024 24 [Abstract]()
[4624-4631] Establishment and validation of nomogram model of gastric cancer risk in patients with chronic gastritis
[GAO Mengjie1,2,GUO Qiqi1,2,SHEN Xin1,2,CAO Jiaojiao1,2,WANG Tengteng1,3,SHI Yongquan1]
2024 24 [Abstract]()
[4632-4637] Expression and clinical significance of PPP1R14B in endometrial cancer tissues
[LIN Lili1,ZHUANG Ying1,DU Shuangxue2,WANG Xiwei3，DUAN Xia1]
2024 24 [Abstract]()
[4638-4643] The expression and clinical significance of ZSWIM4 in ovarian serous cystadenocarcinoma tissues
[ZENG Kai1,2,HU Yuexin1,2,FAN Xiangcheng1,2,LIU Ouxuan1,2,LI Xinru1,2,WEI Xiaojing1,2,XIA Beibei1,2,ZHANG Yuchen1,2,LI Xiao1,2, LIN Bei1,2]
2024 24 [Abstract]()
[4644-4648] Analysis of the therapeutic effect of complete laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma
[LEI Ting1,XIE Jiaokui1,WANG Xiao1，QIU Minghao1，ZHANG Yupu1，DENG Jiuhan1，WANG Chunyang2， FU Weijun2]
2024 24 [Abstract]()
[4649-4653] The efficacy of recombinant interleukin-2 peritumoral injection on local tumor responsiveness and its effect on subsquent symptomatic anxiety improvement
[RONG Xiumei,XU Dazhao,HUO Feifei,GENG Zhenying,LIN Ping,ZHAO Haiyang,WU Tiecheng,WANG Xiaoli]
2024 24 [Abstract]()
[4654-4662] Analysis of the mechanism of Astragalus in treating lung cancer based on network pharmacology and molecular docking
[CHEN Wei1，CUI Yi1，ZOU Mingjun2，YUE Jianren1，ZHANG Xi1，SHI Changbei1，ZHAO Peixi1,ZHANG Yili1]
2024 24 [Abstract]()
[4663-4673] Review of influencing factors and mechanisms of EGFR-TKIs-associated rash in non-small cell lung cancer
[SONG Shanshan,JIANG Fusheng,WANG Liang,HUANG Bozhen,LIU Xinxin,JIANG Min]
2024 24 [Abstract]()
[4674-4679] Research progress of histone deacetylase inhibitors in breast cancer
[DU Yanan1,LI Rutian2,XIE Li2]
2024 24 [Abstract]()
[4680-4686] The molecular mechanism of DDB2 in the occurrence and development of cancer
[ZHOU Wenqian1,2,ZHAO Wenjian1,GUO Jiuru1,WANG Liang1]
2024 24 [Abstract]()
[4687-4692] New progress in the role of synaptotagmin family members in cancer
[ZHAO Yanqing1,YANG Jie2,LIAO Chenggong3,KONG Lingmin2]
2024 24 [Abstract]()